Report Ocean has recently published a new research report on the global autoinjectors market. The study, titled “Autoinjectors Market by Type (Disposable Autoinjectors and Reusable Autoinjectors), Application (Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, and Others), and End user (Homecare Settings and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2020–2027,” is prepared after carrying out a detailed analysis of this market, taking the performance of every market segment into consideration, using various research tools.
According to this report, the worldwide autoinjectors market stood at US$1.5 bn in 2019. Analysts expect this market to proliferate at a CAGR of more than 18.0% over the period of 2020-2027 and reach US$5.7 bn by the end of the forecast period. The rising incidence rate of anaphylaxis and multiple sclerosis, increasing government support in terms of favorable reimbursements policies, and the easy availability of generic versions of autoinjectors are projected to propel this market over the next few years. As per a report published by National Multiple Sclerosis Society, around 1 million adults were living with multiple sclerosis in 2017 in the US alone. As of March 2020, more than 2.3 million people are living with multiple sclerosis across the world and this figure is expected to rise substantially in the near future. This, in turn, is likely to boost the market for autoinjectors across the world over the forthcoming years. However, the easy availability of substitute products, such as oral medicines and general injections may limit the growth of this market in the years to come.
Impact of Covid 19 on Global Autoinjectors Market
The impact of coronavirus pandemic is more or less visible on almost all the markets across the world, including the global autoinjectors market. Due to the economic slowdown, research activities for the development of new and advanced devices have also decreased, reflecting negatively on this market over the last few months. However, with the economies reopening, the market is expected to regain its pace soon.
Disposable Injectors to Register Highest Growth
In this report, the global autoinjectors market has predominantly been analysed on the basis of the type, the application, and the end user. Based on the type, the market has been categorized into disposable and reusable autoinjectors. Among the two, the disposable autoinjectors segment has been leading the global market and is expected to continue to lead during the forecast period.
In terms of the application, the market has been classified into rheumatoid arthritis, anaphylaxis, multiple sclerosis, and others. In 2019, the anaphylaxis segment held the dominant position. Researchers expect this segment to retain the lead over the next few years.
On the basis of end user, the market has been segmented into home care and hospitals and clinics. The home care settings segment has surfaced as the leading end user of autoinjectors and is anticipated to remain so in the years to come.
North America to Acquire Lead
The report also presents a regional analysis of the global Autoinjectors market. It considers Asia Pacific, North America, Europe, Latin America, and the Rest of the World as the key regional market for autoinjectors. Hitherto, North America has been dominating the global market and it expected that this scenario will remain so over the next few years. The increasing government support and the rising demand for high-quality medical products among consumers are projected to support this regional market during the forecast period. The presence of a large pool of market vendors in the region is also anticipated to add to this market’s growth in the years to come.
Apart from this, the autoinjectors market in Asia Pacific is also predicted to report a decent rise in its valuation over the next few years. The increasing prevalence of autoimmune and chronic diseases and the constant improvement in healthcare infrastructure in developing Asian countries will aid this regional market in the near future.
- North America has been dominating the global market and it expected that this scenario will remain so over the next few years.
- The home care settings segment has surfaced as the leading end user of autoinjectors.
The global autoinjectors market is segmented into:
- Disposable Autoinjectors
- Reusable Autoinjectors
- Rheumatoid Arthritis
- Multiple Sclerosis
By End User
- Home Care Settings
- Hospitals & Clinics
- North America
- Asia Pacific
- Latin America
- Rest of the World
Companies Mentioned in the Report
- Antares Pharma
- Becton Dickinson and Company
- Eli Lilly and Company
- Johnson and Johnson
- Mylan N.V.
- Novartis AG
- SHL Medical
- Teva Pharmaceutical Industries Ltd
- Ypsomed AG
Company Name: Report Ocean
Contact Person: Nishi Sharma
Email: Send Email
Address:BSI Business Park,H-15, Sector-63, Noida
State: UP, 201301